vimarsana.com

Page 14 - பல்கலைக்கழகம் ஆஃப் கொலராடோ அண்சச்சுட்ஸ் மருத்துவ வளாகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Study finds similar long-term outcomes for mechanically-ventilated COVID-19 patients

 E-Mail Boston, MA (April 30, 2021) - A new study, presented today at the AATS 101st Annual Meeting, found that severely ill COVID-19 patients treated with ECMO did not suffer worse long-term outcomes than other mechanically-ventilated patients. The multidisciplinary team included cardio thoracic surgeons, critical care doctors, medical staff at long-term care facilities, physical therapists and other specialists, and followed patients at five academic centers: University of Colorado; University of Virginia; University of Kentucky; Johns Hopkins University; and Vanderbilt University. Survivors of critical illness are at high risk for long-term physical, psychological, and cognitive deficits. Extracorporeal membrane oxygenation (ECMO) shows promising survival benefit for select patients with COVID-19. However, its impact on long-term recovery was unknown. The study measured physical, psychological, and cognitive deficits in in 46 patients who were canulated for ECMO compared to a

Regulation Change Could Help Addiction Treatment In The West

The U.S. Department of Health and Human Services is easing restrictions on one of the most effective treatments for opioid addiction. That medication is buprenorphine, and the change makes it so healthcare professionals don’t have to get extra training to offer the medication to as many as 30 patients with opioid addiction. Addiction specialists hailed the move, including Dr. Donald E. Nease, Jr. with the University of Colorado Anschutz Medical Campus. He thinks this is a great step toward acceptance of medications that help in addiction treatment. “Reminds me a lot of early in my career,” Nease said, “when the same thing happened with the routine treatment and primary care of depression.”

Regulation Change Could Help Addiction Treatment In The West

easing restrictions on one of the most effective treatments for opioid addiction. That medication is buprenorphine, and the change makes it so healthcare professionals don’t have to get extra training to offer the medication to as many as 30 patients with opioid addiction. Addiction specialists hailed the move, including Dr. Donald E. Nease, Jr. with the University of Colorado Anschutz Medical Campus. He thinks this is a great step toward acceptance of medications that help in addiction treatment. “Reminds me a lot of early in my career,” Nease said, “when the same thing happened with the routine treatment and primary care of depression.”

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.